Compass Therapeutics Inc

NASDAQ:CMPX   10:22:41 AM EDT
3.07
-0.17 (-5.25%)
Earnings Announcements

Compass Therapeutics Reports Q3 Loss Per Share $0.10

Published: 11/12/2021 13:41 GMT
Compass Therapeutics Inc (CMPX) - Compass Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporate Update.
Q3 Loss per Share $0.10.
Cash and Cash Equivalents With Public Offering Proceeds to Fund Operating Expenses, Capital Expenditures Into Q4 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.08

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.08

More details on our Analysts Page.